Want to join the conversation?
Cowen and Co. analyst Joseph Giordano questions $ROP on the drivers of GM in Medical & Scientific Imaging. CFO John Humphrey says that it is volume driven and the segment has the highest GM across the enterprise, north of 70%. $ROP says that incremental growth on the topside is the main driver of margin improvement during the year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.